A site's ability to accurately forecast how many suitable patients they have for a study is critical to managing risk and the study's overall success. Sponsors and CROs have been reliant on sites to provide these forecasts, however the site's ability to recruit isn't always in line with what was predicted.
The Longboat Feasibility Navigator:
Cycle time from IND filing to NDA submission has increased by 8% since 2005. Higher investment in technology and more systematic practices correlate with more speedy study start up. Tufts Center for the Study of Drug Development
Fill out the form to signup for a demonstration. One of our specialists will follow-up to schedule a one-on-one overview of the technology.